Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 14, 2012; 18(10): 1117-1122
Published online Mar 14, 2012. doi: 10.3748/wjg.v18.i10.1117
Table 3 Clinicopathological characteristics analysis of 220 gastric cancer patients and TBX21 -1993T/C polymorphism n (%)
VariablesAllT/TT/CC/CAdjusted OR (95% CI)P
Age (yr)
≥ 6026 (11.82)21 (80.77)3 (11.54)2 (7.69)1.93 (0.68-5.47) 0.218
< 60194 (88.18)133 (68.55)45 (23.20)16 (8.25)
Gender
Male124 (56.36)82 (66.13)29 (23.39)13 (10.48)0.70 (0.32-1.56) 0.388
Female96 (43.64)72 (75.00)19 (19.79)5 (5.21)
Tumor size
≥ 5 cm123 (55.91)84 (68.29)30 (24.39)9 (7.32)0.75 (0.40-1.41) 0.369
< 5 cm97 (44.09)70 (72.16)18 (18.56)9 (9.28)
Degree of differentiation
G1-2107 (48.64)70 (65.42)23 (21.50)14 (13.08)1.64 (0.87-3.07) 0.124
G3-4113 (51.36)84 (74.34)25 (22.12)4 (3.54)
TNM stage
Stage I/II67 (30.45)47 (70.15)13 (19.40)7 (10.45)0.73 (0.36-1.46) 0.370
Stage III/IV153 (69.55)107 (69.93)35 (22.88)11 (7.19)
Lymph node status
N078 (35.45)66 (84.62)6 (7.69)6 (7.69)4.02 (1.87-8.66)< 0.001
N1-3142 (64.55)88 (61.97)42 (29.58)12 (8.45)
Distant metastasis
M0148 (67.27)121 (81.76)18 (12.16)9 (6.08)7.02 (3.44-14.34)< 0.001
M172 (32.73)33 (45.83)30 (41.67)9 (12.50)